MedTrace Logo

Paravertebral Catheters for VATS Procedures

NCT02361775 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2015-02-12

No results posted yet for this study

Summary

Level I randomized prospective outcomes study comparing two groups of patients. One group will receive Dilaudid patient controlled analgesia (PCA) post-operatively. The other will receive an ultrasound guided paravertebral block with indwelling paravertebral catheter with an infusion of 0.2% Ropivicaine post-operatively and a PCA.

Conditions

  • Acute Pain

Interventions

DEVICE

Paravertebral catheter

A catheter is placed ultrasound guided at the T5 paravertebral level

DEVICE

opioid iv pca

opioid pca consisting of hydromorphone

DRUG

Ropivacaine

0.2% ropivacaine infused through paravertebral catheter

DEVICE

Elastomeric Pump

Elastomeric pump connected to paravertebral catheter

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2014-10-31
Completion
2014-10-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02361775 on ClinicalTrials.gov